Based on the status of three important receptors conventionally used for breast cancer subtyping, i.e., estrogen receptor (ER), progesterone receptor (PR), and human epithelial receptor 2 (HER2), breast cancer is classified as luminal A, luminal B, HER2 positive and triple-negative (“basal-like”). This evidence concerns the gene PGR and breast carcinoma.